Elevated USP8 expression has been identified in various digestive system tumors, including gastric cancer, hepatocellular carcinoma (HCC), cholangiocarcinoma, and pancreatic cancer [35,41,42,43,44,45]. This evidence concerns the gene USP8 and cholangiocarcinoma.